Docetaxel Plus Oxaliplatin as Therapy in Patients With Pancreatic Cancer

NCT00690300 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Pancreas Neoplasms

Interventions

DRUG: Docetaxel
DRUG: Oxaliplatin

Sponsor

University of Ulm